Characterising the molecular basis of cystic kidney diseases using kidney organoids created by directed differentiation of patient-derived, induced pluripotent stem cells.

使用通过患者来源的诱导多能干细胞定向分化产生的肾脏类器官来表征囊性肾病的分子基础。

• 批准号: nhmrc : GNT1114409
• 负责人: Dr Thomas Forbes
• 金额: $ 12.27万
• 依托单位国家: 澳大利亚
• 项目类别: Postgraduate Scholarships
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/characterising-molecular-basis-stem-cells/1346905
• 关键词: Characterising; molecular; basis; cystic; kidney

Inherited genetic mutations cause almost half of chronic kidney diseases in children. In most cases we do not know what the mutation is or how it causes kidney disease. In this study we will turn skin cells from children with kidney disease into stem cells and then use these to make a mini-kidney in a dish. This will act as a model of kidney disease allowing us to understand what the problem is at the level of changes within the cells. This may result in new ways of treating kidney disease.

遗传性基因突变导致几乎一半的儿童慢性肾脏疾病。在大多数情况下，我们不知道突变是什么，也不知道它是如何导致肾脏疾病的。在这项研究中，我们将从患有肾脏疾病的儿童身上提取皮肤细胞，并将其转化为干细胞，然后用这些干细胞在培养皿中制造出一个迷你肾脏。这将作为肾脏疾病的模型，使我们能够了解细胞内变化水平的问题。这可能会导致治疗肾脏疾病的新方法。